News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,095 Results
Type
Article (17689)
Company Profile (38)
Press Release (268368)
Section
Business (81228)
Career Advice (162)
Deals (12549)
Drug Delivery (27)
Drug Development (37223)
Employer Resources (19)
FDA (5293)
Job Trends (4181)
News (135379)
Policy (10445)
Tag
Academia (640)
Alliances (21996)
Alzheimer's disease (391)
Antibody-drug conjugate (ADC) (44)
Approvals (5289)
Artificial intelligence (67)
Bankruptcy (79)
Best Places to Work (3628)
Breast cancer (110)
Cancer (850)
Cardiovascular disease (58)
Career advice (140)
CAR-T (67)
Cell therapy (159)
Clinical research (30070)
Collaboration (288)
Compensation (118)
COVID-19 (1886)
C-suite (68)
Data (870)
Diabetes (67)
Diagnostics (2023)
Earnings (22579)
Events (50590)
Executive appointments (253)
FDA (5660)
Funding (275)
Gene therapy (98)
GLP-1 (174)
Government (1349)
Healthcare (4859)
Infectious disease (1930)
Inflammatory bowel disease (44)
IPO (4891)
Job creations (880)
Job search strategy (124)
Layoffs (82)
Legal (2355)
Lung cancer (121)
Lymphoma (91)
Manufacturing (81)
Medical device (2733)
Medtech (2733)
Mergers & acquisitions (7867)
Metabolic disorders (174)
Neuroscience (542)
NextGen: Class of 2025 (1567)
Non-profit (608)
Northern California (921)
Obesity (84)
Opinion (111)
Parkinson's disease (44)
People (33147)
Phase I (10109)
Phase II (13909)
Phase III (9175)
Pipeline (358)
Postmarket research (1008)
Preclinical (3600)
Radiopharmaceuticals (58)
Rare diseases (124)
Real estate (1708)
Regulatory (7393)
Research institute (608)
Series A (49)
Series B (58)
Southern California (725)
Startups (1887)
United States (7216)
Vaccines (331)
Date
Today (68)
Last 7 days (513)
Last 30 days (1197)
Last 365 days (14397)
2025 (760)
2024 (14146)
2023 (13782)
2022 (19280)
2021 (22408)
2020 (19415)
2019 (10455)
2018 (7945)
2017 (14273)
2016 (16848)
2015 (21248)
2014 (15945)
2013 (13441)
2012 (13882)
2011 (13558)
2010 (11844)
Location
Africa (284)
Arizona (62)
Asia (17804)
Australia (2638)
California (1997)
Canada (684)
China (149)
Colorado (99)
Connecticut (118)
Delaware (66)
Europe (42488)
Florida (218)
Georgia (66)
Illinois (203)
Indiana (58)
Japan (57)
Maryland (228)
Massachusetts (1557)
Michigan (49)
Minnesota (88)
New Jersey (549)
New York (541)
North Carolina (279)
Northern California (921)
Ohio (47)
Pennsylvania (357)
South America (527)
Southern California (725)
Texas (321)
Washington State (229)
286,095 Results for "cergentis b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
January 7, 2025
·
3 min read
Press Releases
MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
December 17, 2024
·
5 min read
Pharm Country
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life Sciences, B.V. to Nordic Group, B.V., a subsidiary of SEVER Life Sciences B.V., which occurred on June 1, 2023.
March 4, 2024
·
3 min read
Deals
Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Clade Therapeutics today announced that it has completed the acquisition of Gadeta B.V.
October 2, 2023
·
4 min read
Press Releases
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2
November 14, 2024
·
7 min read
Press Releases
Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024
October 28, 2024
·
9 min read
Pharm Country
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye.
Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., has launched LACRIFILL Canalicular Gel, a novel therapy for dry eye in the U.S. LACRIFILL Canalicular Gel is a cross-linked hyaluronic acid derivative and is FDA-cleared to temporarily block tear drainage by the occlusion of the canalicular system.
May 29, 2024
·
3 min read
Business
Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”) today announced that it will report its First Quarter 2024 Earnings Results on Wednesday, April 24, 2024, after the Mexican Stock Exchange (BMV) close.
April 4, 2024
·
2 min read
Press Releases
Vetter introduces the next evolution of the V-OVS® syringe closure system
January 14, 2025
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease
January 14, 2025
·
10 min read
1 of 28,610
Next
